RESUMEN
The only molecular defect reported for the X-linked immunodeficiency Wiskott-Aldrich syndrome (WAS) is the abnormal electrophoretic behavior of the major T lymphocyte sialoglycoprotein CD43. Since the 70 to 80 O-linked carbohydrate chains of CD43 are known to influence markedly its electrophoretic mobility, we analyzed the structure and the biosynthesis of O-glycans of CD43 in lymphocytes from patients with WAS. Immunofluorescence analysis with the carbohydrate dependent anti-CD43 antibody T305 revealed that in 10 out of the 12 WAS patients tested increased numbers of T lymphocytes carry on CD43 an epitope which on normal lymphocytes is expressed only after activation. Other activation antigens were absent from WAS lymphocytes. Western blots of WAS cell lysates displayed a high molecular mass form of CD43 which reacted with the T305 antibody and which could be found on in vivo activated lymphocytes but was absent from normal unstimulated lymphocytes. To examine the O-glycan structures, carbohydrate labeled CD43 was immunoprecipitated and the released oligosaccharides identified. WAS lymphocyte CD43 was found to carry predominantly the branched structure NeuNAc alpha 2----3Gal beta 1----3 (NeuNAc alpha 2----3Gal beta 1----4G1cNAc beta 1----6) GalNAcOH whereas normal lymphocytes carry the structure NeuNAc alpha 2----3Gal beta 1----3 (NeuNAc alpha 2----6) GalNAcOH. Only after activation NeuNAc alpha 2----3Gal beta 1----3 (NeuNAc alpha 2----3Gal beta 1----4GlcNAc beta 1----6) GalNAcOH becomes the principal oligosaccharide on CD43 from normal lymphocytes. Analyzing the six glycosyltransferases involved in the biosynthesis of these O-glycan structures it was found that in WAS lymphocytes high levels of beta 1----6 N-acetyl-glucosaminyl transferase are responsible for the expression of NeuNAc alpha 2----3Gal beta 1----3 (NeuNAc alpha 2----3Gal beta 1----4GlcNAc beta 1----6) GalNAcOH on CD43. The gene responsible for WAS has not yet been identified but the results presented in this study suggest that the primary defect in WAS may affect a gene which is involved in the regulation of O-glycosylation.
Asunto(s)
Antígenos CD/metabolismo , Linfocitos/metabolismo , Sialoglicoproteínas/metabolismo , Síndrome de Wiskott-Aldrich/metabolismo , Antígenos CD/química , Secuencia de Carbohidratos , Citometría de Flujo , Glicosilación , Hexosiltransferasas/metabolismo , Humanos , Leucosialina , Activación de Linfocitos , Subgrupos Linfocitarios/química , Datos de Secuencia Molecular , Peso Molecular , Oligosacáridos/química , Procesamiento Proteico-Postraduccional , Sialoglicoproteínas/químicaRESUMEN
Liver cancer is one of the most frequent and lethal malignancies worldwide. Early detection is hampered by the absence of reliable markers. Mice transgenic for the SV40 large T antigen under the control of a liver-specific promoter spontaneously develop well-differentiated hepatocellular carcinomas between 8 to 10 weeks of age. They are excellent models to investigate the alterations of protein expression in the early stages of tumor development and to follow these changes during tumor progression. In the present study, we analyzed the glycosylation changes occurring during tumor development in transgenic mice expressing the SV40 T antigen under the control of the antithrombin III promoter. The analysis of serum and liver glycoproteins by an ELISA type assay, using the lectin from Sambucus nigra (SNA) as a probe, revealed the presence of increased levels of Neu5Ac alpha2,6Gal beta1,4GlcNAc on N-glycans in the tumor-bearing transgenic mice as compared to controls. On serum glycoproteins the increase in alpha2,6 sialylation followed tumor progression, reaching up to 10 times control levels. However, significantly higher SNA binding (2-fold) could already be observed on serum glycoproteins from mice exhibiting only microscopically small neoplastic foci. On liver membrane glycoproteins, the increase in alpha2,6 sialylation was less pronounced, reaching two to three times control values in 6-month-old mice. Western blotting of serum and liver proteins with radiolabeled SNA showed that all glycoproteins that bind the lectin in controls exhibit larger amounts of Neu5Ac alpha2,6Gal beta1,4GlcNAc on N-glycans in the tumor-bearing mice. This general increase in alpha2,6 sialylation on all glycoproteins is due to the increased activity of the galactoside:alpha2,6 sialyltransferase (ST6Gal I), which specifically transfers Neu5Ac residues in alpha2,6 linkage to Gal beta1,4GlcNAc units on N-glycans. As for the structures synthesized by the enzyme, the increase of ST6Gal I activity in the serum as well as in liver microsomes of the transgenic mice followed tumor progression. Interestingly, the activity of the galactoside:alpha2,3 sialyltransferase (ST3Gal III), which uses the same acceptor substrate (Gal beta1,4GlcNAc), was unchanged in the earlier stages of tumor development but decreased in the serum and in liver microsomes from later stages. Using a rat ST6Gal I cDNA as a probe, Northern blots of total RNA extracted from the livers of control and transgenic mice revealed an increased (4-fold) expression of the ST6Gal I gene. The single transcripts detected in both normal and cancerous liver showed identical size.
Asunto(s)
Neoplasias Hepáticas Experimentales/metabolismo , Ácido N-Acetilneuramínico/metabolismo , Lectinas de Plantas , Polisacáridos/metabolismo , Procesamiento Proteico-Postraduccional , Sialiltransferasas/metabolismo , Animales , Antígenos Virales de Tumores/fisiología , Proteínas Sanguíneas/metabolismo , Secuencia de Carbohidratos , Progresión de la Enfermedad , Inducción Enzimática , Ensayo de Inmunoadsorción Enzimática , Regulación Neoplásica de la Expresión Génica , Glicoproteínas/metabolismo , Glicosilación , Lectinas/metabolismo , Neoplasias Hepáticas Experimentales/patología , Ratones , Ratones Transgénicos , Microsomas Hepáticos/metabolismo , Datos de Secuencia Molecular , Proteínas de Neoplasias/metabolismo , ARN Mensajero/análisis , ARN Mensajero/genética , ARN Neoplásico/análisis , ARN Neoplásico/genética , Ratas , Proteínas Inactivadoras de Ribosomas , Sialiltransferasas/genética , Virus 40 de los Simios/genéticaRESUMEN
Alpha 3-fucosylation of protein or lipid substrates is an important component of the host/parasite interactions during schistosomiasis. In this process, alpha3-fucosyltransferases (alpha3-FucTs) are considered as key enzymes ensuring both parasite survival and adaptation in their (in)vertebrate hosts. In this paper, we report the molecular cloning of a putative alpha3-FucT from Schistosoma mansoni that we termed SmFucTA. The full-length SmFucTA encodes a typical transmembrane type II protein with a short cytoplasmic domain, a transmembrane segment and a long C-terminal catalytic domain. In this region, the GDP-fucose binding site is well conserved whereas the putative acceptor site displays sequence divergence compared to the corresponding region from vertebrate and invertebrate alpha3-FucTs. Southern blot analysis suggested that SmFucTA is present as several copies or has highly related counterparts in the S. mansoni genome. Northern blot revealed a single SmFucTA transcript at 2 kb in adult worms. Affinity purified antibodies directed against recombinant SmFucTA identified a 50 kDa native protein that localizes to the subtegumental and parenchymal regions of adult worms.
Asunto(s)
Clonación Molecular , Fucosiltransferasas/genética , Fucosiltransferasas/metabolismo , Schistosoma mansoni/enzimología , Secuencia de Aminoácidos , Animales , Western Blotting , Cricetinae , ADN Complementario/genética , Escherichia coli/genética , Escherichia coli/metabolismo , Técnica del Anticuerpo Fluorescente , Fucosiltransferasas/química , Datos de Secuencia Molecular , Proteínas Recombinantes de Fusión/aislamiento & purificación , Proteínas Recombinantes de Fusión/metabolismo , Schistosoma mansoni/genética , Esquistosomiasis mansoni/parasitología , Análisis de Secuencia de ADNRESUMEN
To determine the role of the terminal alpha-galactosyl residue in the endothelial damage mediated by human xenoreactive natural antibodies (IgM and IgG), we treated porcine endothelial cells in culture with green coffee bean alpha-galactosidase. A practically complete removal of terminal alpha-Gal residues (as evaluated by flow cytometry with Bandeiraea simplicifolia isolectin B4) and concomitant exposure of N-acetyllactosamine were obtained without altering cell viability. A dramatic decrease in IgM and IgG binding (from a pool of human sera) was observed, confirming the key role of the alpha-galactosyl residues. The enzyme treatment did not induce any nonspecific immunoglobulin binding sites, but led to the exposure of new epitopes for a minor fraction of IgM. The main residual IgM and IgG binding could be due to xenoantigens other than the alpha-galactosyl residues. When alpha-galactosidase-treated endothelial cells were used as targets in cytotoxicity experiments, they were less susceptible than untreated cells to complement-mediated cytotoxicity induced by fresh human serum. In contrast, they did not acquire resistance to human IgG-dependent cellular cytotoxicity, despite the decrease in IgG binding. Because it is known that antibody-dependent cytotoxicity mediated by CD16+ NK cells is dependent on IgG1 and IgG3, and not on IgG2 or IgG4, which was confirmed by blocking experiments, we studied the binding of all four subclasses to intact and alpha-galactosidase-treated endothelial cells. Two major subclasses, IgG1 and IgG2, bound to untreated endothelial cells, whereas IgG3 binding was low and IgG4 binding was negligible. A decrease in IgG1, IgG2, and IgG3 binding was observed upon alpha-galactosidase treatment, indicating that antibodies belonging to these three subclasses recognize alpha-galactosyl residues. The decrease in IgG2 binding was more pronounced than the decrease in IgG1 binding. Collectively, these data indicate that IgG1 xenoreactive natural antibodies, including those which are not directed at the alpha-galactosyl residues, could play a major role in the early delayed vascular rejection of pig xenografts.
Asunto(s)
Endotelio Vascular/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Citotoxicidad Celular Dependiente de Anticuerpos , Proteínas del Sistema Complemento/inmunología , Citotoxicidad Inmunológica , Mapeo Epitopo , Galactosidasas/metabolismo , Galactósidos/inmunología , Humanos , Inmunoglobulina G/inmunología , Inmunoglobulina M/inmunología , Ratones , Relación Estructura-Actividad , Porcinos/inmunologíaRESUMEN
We have determined that the mammalian uridine diphospho-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase T1 (EC 2.4.1.41) has the appropriate acceptor substrate specificity to recognize the non-glycosylated form of contulakin-G (ZSEEGGSNATKKPYIL-OH where Z=pyroglutamic acid) and to transfer GalNAc to the peptide. Both [Thr(10)] contulakin-G and a pre-contulakin-G(30-66) (RGLVPDDITPQLILGSLISRRQSEEGGSNATKKPYIL-OH) were shown to be acceptors for the mammalian enzyme. The site of attachment of the GalNAc residue was determined using chemical and radioactive sequencing techniques. The mammalian enzyme was highly specific for Thr(10) residue, in which the native peptide was found to be glycosylated, compared with either Ser(2) or Ser(7). In the case of pre-contulakin-G, the enzyme was also highly specific for the equivalent threonine residue. These results suggest that the Cone snail uses an enzyme with similar acceptor specificity to that of the mammalian polypeptide N-acetylgalactosaminyltransferase for glycosylating contulakin-G.
Asunto(s)
Glicoproteínas/metabolismo , Venenos de Moluscos/metabolismo , N-Acetilgalactosaminiltransferasas/metabolismo , Neuropéptidos/metabolismo , Secuencia de Aminoácidos , Animales , Glicoproteínas/química , Glicosilación , Mamíferos , Datos de Secuencia Molecular , Venenos de Moluscos/química , Neuropéptidos/químicaRESUMEN
Microsomal preparations from human kidney were found to contain enzymic activity capable to transfer N-acetylgalactosamine from UDP-N-acetylgalactosamine to native bovine fetuin. The acceptor structures on the fetuin molecules were identified as N- as well as O-linked glycans with a markedly higher incorporation into the N-linked carbohydrate chains. Analysis of the alkali-labile transferase products by thin-layer chromatography indicated that the enzyme is able to synthesize structures having mobilities identical with those found on glycophorin from Cad erythrocytes. Mild acid treatment and enzymic hydrolysis with N-acetylhexosaminidase from jack beans of the N-linked transferase products suggested that beta-D-GalpNAc-(1----4)-[alpha-NeuAc-(2----3)]-beta-D-Galp-(1----s tructures were formed by the enzymic reaction on both N- and O-linked acceptors. The enzyme might, therefore, be involved in the biosynthesis of Sda (and Cad) antigenic structures. By use of various oligosaccharides, glycopeptides, and glycolipids having well characterized carbohydrate sequences, the acceptor-substrate specificity of the N-acetylgalactosaminyltransferase was determined. The enzyme generally recognized alpha-NeuAc-(2----3)-beta-D-Gal groups as acceptors, but in a certain conformation. Thus, tri- and tetra-saccharide alditols, native human glycophorin A, and GM3 were not acceptor substrates although they carry the potential disaccharide acceptor unit. When these structures were presented as sialyl-(2----3)-lactose or as a tryptic peptide from glycophorin A, they were shown to be rather good acceptor substrates for the N-acetyl-beta-D-galactosaminyltransferase from human kidney.
Asunto(s)
Galactosiltransferasas/metabolismo , Riñón/enzimología , N-Acetilgalactosaminiltransferasas , Animales , Conformación de Carbohidratos , Secuencia de Carbohidratos , Radioisótopos de Carbono , Bovinos , Glucolípidos , Glicoproteínas , Humanos , Cinética , Especificidad por Sustrato , alfa-FetoproteínasRESUMEN
On human erythrocytes, the membrane components associated with Pk and P1 blood-group specificity are glycosphingolipids that carry a common terminal alpha-D-Galp-(1----4)-beta-D-Gal unit, the biosynthesis of which is poorly understood. Human kidneys typed for P1 and P2 (non-P1) blood-group specificity have been assayed for (1----4)-alpha-D-galactosyltransferase activity by use of lactosylceramide [beta-D-Galp-(1----4)-beta-D-Glcp-ceramide] and paragloboside [beta-D-Galp-(1----4)-beta-D-GlcpNAc-(1----3)-beta-D-Galp- (1----4)-beta-D-Glcp-ceramide] as acceptor substrates. The linkage and anomeric configuration of the galactosyl group transferred into the reaction products were established by methylation analysis before and after alpha- and beta-D-galactosidase treatments, as well as by immunostaining using specific monoclonal antibodies directed against the Pk and P1 antigens. The results demonstrated that the microsomal proteins from P1 kidneys catalyze the synthesis of Pk [alpha-D-Galp-(1----4)-beta-D-Galp-(1----4)-beta-D-Glcp-ceramide] and P1 [alpha-D-Galp-(1----4)-beta-D-Galp-(1----4)-beta-D-GlcpNAc-(1----3)-beta -D-Galp-(1----4)-beta-D-Glcp-ceramide] glycolipids, whereas microsomes from P2 kidney catalyze the synthesis of the Pk glycolipid, but not of the P1 glycolipid. Competition studies using a mixture of two oligosaccharides (methyl beta-lactoside and methyl beta-lacto-N- neotetraoside) or of two glycolipids (lactosylceramide and paragloboside) as acceptors indicated that these substrates do not compete for the same enzyme in the microsomal preparation from P1 kidneys. The results suggested that the Pk and P1 glycolipids are synthesized by two distinct enzymes.
Asunto(s)
Antígenos CD , Galactosiltransferasas/metabolismo , Glucolípidos/biosíntesis , Riñón/metabolismo , Lactosilceramidos , Microsomas/metabolismo , Sistema del Grupo Sanguíneo P/biosíntesis , Secuencia de Carbohidratos , Globósidos/metabolismo , Glicoesfingolípidos/metabolismo , Humanos , Isoenzimas , Isomerismo , Datos de Secuencia Molecular , Especificidad por SustratoRESUMEN
Glycoproteins from the human T leukemia cells Jurkat were found to bind to the GalNAc alpha 1----Ser/Thr-specific lectin from Salvia sclarea seeds. The analysis of the O-linked saccharides of immunopurified leukosialin, the major [3H]glucosamine-labeled glycoprotein in Jurkat cell lysate, revealed the presence of mainly GalNAc alpha 1----Ser/Thr with only minor amounts (approximately 17%) of more complex O-glycans. A comparison between Jurkat and K562 cell glycosyltransferase involved in the biosynthesis of O-linked carbohydrates showed that a markedly lower activity of UDP-Gal:GalNAc alpha 1----Ser/Thr beta 1----3galactosyltransferase is apparently responsible for the presence of truncated O-glycans in the Jurkat cell line. The O-glycosylation defect makes Jurkat cells an ideal model to study the initiation of O-linked saccharides. Pulse-chase experiments with [35S] methionine showed that the addition of GalNAc to leukosialin is responsible for the decreased mobility of the mature glycoprotein on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Furthermore, no biosynthetic intermediates between the O-glycan-free precursor and the fully O-glycosylated form could be detected either with an anti-leukosialin antiserum or with the GalNAc-specific lectin. Lowering the chase temperature to 15 degrees C completely inhibited the transfer of GalNAc to the peptide core indicating that O-glycan initiation takes place in the first Golgi elements and not in transitional vesicles between endoplasmic reticulum and Golgi. In addition, treatment of the cells with monensin did not inhibit GalNAc transfer to leukosialin apoprotein. These results indicate that the initiation of O-glycosylation in Jurkat cells starts in the cis-Golgi stacks.
Asunto(s)
Antígenos CD , Leucemia Linfoide/metabolismo , Polisacáridos/biosíntesis , Acetilgalactosamina/metabolismo , Conformación de Carbohidratos , Secuencia de Carbohidratos , Electroforesis en Gel de Poliacrilamida , Galactosiltransferasas/metabolismo , Glicoproteínas/metabolismo , Glicosilación , Humanos , Técnicas de Inmunoadsorción , Lectinas/metabolismo , Leucosialina , Datos de Secuencia Molecular , Sialoglicoproteínas/metabolismo , Células Tumorales CultivadasRESUMEN
Leukosialin (CD43) is a heavily O-glycosylated membrane glycoprotein present on all leukocytes and on platelets. We found that leukosialin is phosphorylated in erythroid, myeloid, and T-lymphoid cell lines, as well as in platelets and peripheral blood lymphocytes. Leukosialin phosphorylation was increased 2.5-15-fold following phorbol ester treatment. The phosphorylation could be inhibited with the protein kinase C inhibitor staurosporine but not with HA 1004 that inhibits cAMP- or cGMP-dependent protein kinases. The phosphoamino acid analysis showed that serine residues were exclusively phosphorylated, either with or without phorbol ester treatment. Two-dimensional peptide maps of phosphorylated leukosialin from K562 and Jurkat cells gave almost identical patterns. The number of labeled peptides increased after treatment with phorbol ester, indicating that new sites were phosphorylated. The major phosphorylation site on leukosialin was identified as Ser-332 in a region of the cytoplasmic domain located 73 amino acids from the transmembrane portion.
Asunto(s)
Antígenos CD , Sialoglicoproteínas/metabolismo , Acetato de Tetradecanoilforbol/farmacología , Alcaloides/farmacología , Secuencia de Aminoácidos , Plaquetas/metabolismo , Línea Celular , Eritrocitos/metabolismo , Granulocitos/metabolismo , Humanos , Cinética , Leucosialina , Datos de Secuencia Molecular , Fragmentos de Péptidos/metabolismo , Mapeo Peptídico , Fosfatos/metabolismo , Fosforilación , Fosfoserina/metabolismo , Proteína Quinasa C/antagonistas & inhibidores , Estaurosporina , Linfocitos T/metabolismoRESUMEN
A beta 1-3-N-Acetylglucosaminyltransferase has been detected in human serum which transfers N-acetylglucosamine residues from UDP-GlcNAc to terminal Gal beta 1-4Glc(NAc) structures in oligosaccharides, glycoproteins, glycolipids, and proteoglycans. The product of the transferase reaction with lactose as acceptor was identified by methylation analysis and mass spectrometry as GlcNAc beta 1-3Gal beta 1-4Glc. The beta-linkage of the GlcNAc in the synthesized trisaccharide was confirmed by the action of the specific enzymes beta-hexosaminidase and beta-N-acetylglucosaminide beta 1-4-galactosyltransferase. Kinetic parameters were determined for UDP-GlcNAc, lactose, and N-acetyllactosamine. The enzyme requires Mn2+ ions for maximal activity and shows a pH optimum between 6 and 8. Using a wide variety of synthetic and natural oligosaccharides, the substrate specificity of the beta 1-3N-acetylglucosaminyltransferase was investigated. The enzyme was found to recognize specifically the free terminal structure Gal beta 1-4Glc(NAc). The substrate specificity was found to be equally stringent for glycoconjugates. Among the glycoproteins and glycolipids tested as acceptors, N-acetylglucosamine was incorporated only into those containing free terminal Gal beta 1-4Glc(NAc) structures. When the terminal galactose residues were partially removed, the transfer of N-acetylglucosamine was strongly reduced.
Asunto(s)
N-Acetilglucosaminiltransferasas/sangre , Conformación de Carbohidratos , Secuencia de Carbohidratos , Radioisótopos de Carbono , Humanos , Cinética , Manganeso/farmacología , Espectrometría de Masas , Oligosacáridos/metabolismo , Especificidad por SustratoRESUMEN
Seven plant lectins, Dolichos biflorus agglutinin (DBA), Griffonia simplicifolia agglutinin (GSA, isolectin A4), Helix pomatia agglutinin (HPA), soybean (Glycine max) agglutinin (SBA), Salvia sclarea agglutinin (SSA), Vicia villosa agglutinin (VVA, isolectin B4) and Wistaria floribunda agglutinin (WFA), known to be specific for N-acetyl-D-galactosamine-(GalNAc) bearing glycoconjugates, have been compared by the binding of their radiolabelled derivatives, to eight well-characterized synthetic oligosaccharides immobilized via a spacer on an inert silica matrix (Synsorb). The eight oligosaccharides included the Forssman, the blood group A and the T antigens, as well as alpha GalNAc coupled directly to the support (Tn antigen) and also structures with GalNAc linked alpha or beta to positions 3 or 4 of an unsubstituted Gal. The binding studies clearly distinguished the lectins into alpha GalNAc-specific agglutinins like DBA, GSA and SSA, and lectins which recognize alpha- as well as beta-linked GalNAc residues like HPA, VVA, WFA and SBA. HPA was the only lectin which bound to the beta Gal1----3 alpha GalNAc-Synsorb adsorbent (T antigen) indicating that it also recognizes internal GalNAc residues. Among the alpha GalNAc-specific lectins, DBA strongly recognized blood group A structures while GSA displayed weaker recognition, and SSA bound only slightly to this affinity matrix. In addition, DBA and SSA were able to distinguish between GalNAc linked alpha 1----3 and GalNAc linked alpha 1----4, to the support, the latter being a much weaker ligand. These results were corroborated by the binding of the lectins to biological substrates as determined by their hemagglutination titers with native and enzyme-treated red blood cells carrying known GalNAc determinants, e.g. blood group A, and the Cad and Tn antigens. For SSA, the binding to the alpha GalNAc matrix was inhibited by a number of glycopeptides and glycoproteins confirming the strong preference of this lectin for alpha GalNAc-Ser/Thr-bearing glycoproteins.
Asunto(s)
Acetilgalactosamina/metabolismo , Galactosamina/análogos & derivados , Lectinas/metabolismo , Oligosacáridos/metabolismo , Sitios de Unión/efectos de los fármacos , Antígenos de Grupos Sanguíneos , Secuencia de Carbohidratos , Eritrocitos/efectos de los fármacos , Eritrocitos/inmunología , Eritrocitos/metabolismo , Glicopéptidos/farmacología , Glicoproteínas/farmacología , Pruebas de Hemaglutinación , Humanos , Lectinas/clasificación , Datos de Secuencia MolecularRESUMEN
Two galactosyltransferases identified as UDP-galactose:lactose (lactosylceramide) alpha-4- and beta-3-galactosyltransferases [Bailly P. et al. (1986) Biochem. Biophys. Res. Commun. 141, 84-91] have been characterized in human kidney microsomes. Using methyl beta-D-galactoside as acceptor substrate, we have determined the experimental conditions (pH 5.0, 4 mM Cd2+) in which only the beta-3-galactosyltransferase activity is detectable. The reaction product has been characterized by chemical methods and glycosidase studies. Under these experimental conditions, some of the enzyme properties have been further investigated. Apparent Km values are for UDP-galactose, 0.170 mM; for lactose, 242 mM; and for lactosylceramide, 2.5 mM. Acceptor specificity studies suggest that the beta-3-galactosyltransferase is specific for terminal Gal beta 1-4Glc(NAc) residues and responsible for elongation of oligosaccharide chains in glycolipids. Competition studies with lactose and N-acetylgalactosamine as acceptor substrates indicate that the transferase described here can be distinguished from the UDP-galactose:2-acetamide-2-deoxy-D-galactose beta-3-galactosyltransferase and therefore represents a novel enzyme capable of synthesizing unusual carbohydrate structures similar to those which accumulate in certain neurological diseases.
Asunto(s)
Galactosiltransferasas/aislamiento & purificación , Riñón/enzimología , Cadmio/farmacología , Cloruro de Cadmio , Glucolípidos/biosíntesis , Humanos , Concentración de Iones de Hidrógeno , Metilación , Microsomas/enzimología , Especificidad por SustratoRESUMEN
Two major lysosomal membrane glycoproteins with apparent Mr approximately 120,000 were purified from chronic myelogenous leukemia cells. These glycoproteins are major sialoglycoproteins containing polylactosaminoglycan and represent approximately 0.1-0.2% of total cell proteins. A monoclonal antibody specific to one of the glycoproteins and polyclonal antibodies specific to the other glycoprotein were obtained. Immunoelectron microscopic examination of HeLa cells revealed that these two glycoproteins mainly reside in lysosomes and multivesicular bodies. Immunoprecipitation experiments showed that a number of different cell lines express these glycoproteins. However, the apparent molecular weights differed between cell lines; this probably represents differences in the amount of polylactosaminoglycan expressed by each cell line. As shown in the following paper (Fukuda, M., Viitala, J., Matteson, J., and Carlsson, S. R. (1988) J. Biol. Chem. 263, 18920-18928) one of the glycoproteins is very homologous to that of a mouse counterpart, m-lamp-1. The human form of this glycoprotein is therefore named human lamp-1 (h-lamp-1), while the other glycoprotein, to which the monoclonal antibody was made, is called human lamp-2 (h-lamp-2). Pulse-chase labeling experiments detected that h-lamp-1 and h-lamp-2 are produced first as precursor forms of 87.5 and 84 kDa, and treatment with endo-beta-N-acetylglucosaminidase H (endo-H) or endo-beta-N-acetylglucosaminidase F (endo-F) reduced their molecular masses to 39.5 and 41.5 kDa, respectively. It was estimated that h-lamp-1 has 18 N-linked saccharides and h-lamp-2 16, based on the results of partial digestions with endo-F. These results indicate that the two lysosomal membrane glycoproteins are extensively modified by N-glycans, and some of these were found to have polylactosaminyl repeats and sialic acid. Human lamp-1 and lamp-2, therefore, serve as good models for understanding polylactosaminoglycan formation and the biosynthesis and processing of polylactosaminoglycan-containing glycoprotein.
Asunto(s)
Amino Azúcares/análisis , Antígenos CD , Lisosomas/análisis , Glicoproteínas de Membrana/aislamiento & purificación , Polisacáridos/análisis , Sialoglicoproteínas/análisis , Aminoácidos/análisis , Anticuerpos Monoclonales , Carbohidratos/análisis , Línea Celular , Glicósido Hidrolasas/metabolismo , Humanos , Leucemia Mieloide Aguda/metabolismo , Proteínas de Membrana de los Lisosomas , Manosil-Glicoproteína Endo-beta-N-Acetilglucosaminidasa , Peso Molecular , PolímerosRESUMEN
The activation of human T-lymphocytes by anti-CD3 antibodies and interleukin-2 results in a marked increase in apparent molecular weight of the major cell-surface sialoglycoprotein. Both forms of the sialoglycoprotein were identified as leukosialin by a monospecific antiserum, and the differences in molecular weight were found to be due to changes in the carbohydrate structures. Our results suggest that resting T-lymphocytes express on leukosialin the disialotetrasaccharides NeuNAc alpha 2----3Gal beta 1----3(NeuNAc alpha 2----6)Gal-NAc-Ser/Thr, whereas activated human T-cells carry on leukosialin exclusively the more complex structures NeuNAc alpha 2----3Gal beta 1----3(NeuNAc alpha 2----3Gal beta 1----4GlcNAc beta 1----6)GalNAc-Ser/Thr. The radical shift in the biosynthetic pathway of O-glycans in activated T-lymphocytes compared to resting cells is apparently caused by a decrease of alpha 2----6 sialyltransferase activity and by the parallel dramatic stimulation of the beta 1----6GlcNAc-transferase. Since both enzymes compete for the same precursor substrate, the coordinate changes in their activities are most likely responsible for the complete change of the carbohydrate structures on leukosialin during the activation of human T-lymphocytes.
Asunto(s)
Antígenos CD , Activación de Linfocitos , Polisacáridos/biosíntesis , Sialoglicoproteínas/biosíntesis , Linfocitos T/inmunología , Conformación de Carbohidratos , Secuencia de Carbohidratos , Humanos , Sueros Inmunes , Técnicas In Vitro , Leucosialina , Datos de Secuencia Molecular , Oligosacáridos/aislamiento & purificación , Sialoglicoproteínas/aislamiento & purificación , Linfocitos T/metabolismoRESUMEN
Transgenic mice expressing the Simian virus 40 large T antigen under the control of the liver-specific human antithrombin-III promoter all develop well-differentiated hepatocellular carcinoma. During tumour development serum ceruloplasmin (Cp) increases gradually until it reaches 30 times control levels in all transgenic mice at 6 months of age. The accumulation of Cp in the serum is due to the increased transcription of the Cp gene as well as to the increase in Cp mRNA stability in the livers of the transgenic mice. One-half of the overproduced Cp is charged with copper and Cp-associated serum oxidase activity increases in parallel with the holo-Cp concentration. Through its ferroxidase activity Cp is involved prominently in iron metabolism. Analysis of copper and iron in serum and liver revealed increased copper levels in the serum of tumour-bearing animals and which increased in parallel with Cp concentration; the amounts of copper in the liver were unchanged. In contrast, serum iron remained constant during tumour development whereas the iron concentration in the livers of the transgenic mice decreased.
Asunto(s)
Carcinoma Hepatocelular/sangre , Ceruloplasmina/metabolismo , Neoplasias Hepáticas/sangre , Animales , Antígenos Virales de Tumores/genética , Antígenos Virales de Tumores/metabolismo , Antitrombina III/genética , Carcinoma Hepatocelular/enzimología , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/metabolismo , Ceruloplasmina/química , Ceruloplasmina/genética , Ceruloplasmina/aislamiento & purificación , Cromatografía por Intercambio Iónico , Cobre/sangre , Cobre/metabolismo , Electroforesis en Gel Bidimensional , Glicoproteínas/química , Glicoproteínas/genética , Glicoproteínas/aislamiento & purificación , Glicoproteínas/metabolismo , Holoenzimas/química , Holoenzimas/genética , Holoenzimas/metabolismo , Hierro/sangre , Hierro/metabolismo , Hígado/enzimología , Hígado/metabolismo , Hígado/patología , Neoplasias Hepáticas/enzimología , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/metabolismo , Ratones , Ratones Transgénicos , Peso Molecular , Regiones Promotoras Genéticas/genética , Estabilidad del ARN , ARN Mensajero/genética , ARN Mensajero/metabolismo , Virus 40 de los Simios/genética , Transgenes/genéticaRESUMEN
Crude extracts from Salvia sclarea seeds were known to contain a lectin which specifically agglutinates Tn erythrocytes (Bird, G. W. G., and Wingham, G. (1974) Vox Sang. 26, 163-166). We have purified the lectin to homogeneity by ion-exchange chromatography and affinity chromatography. The agglutinin was found to be a glycoprotein of Mr = 50,000, composed of two identical subunits of Mr = 35,000 linked together by disulfide bonds. The purified lectin agglutinates specifically Tn erythrocytes and, at higher concentrations, also Cad erythrocytes. Native A, B, or O red blood cells are not agglutinated by the lectin and, even after treatment with sialidase or papain, these cells are not recognized. Tn red cells present 1.45 X 10(6) accessible sites to the lectin which binds to these erythrocytes with an association constant of 1.8 X 10(6) M-1. On Cad red cells, 1.73 X 10(6) sites are accessible to the lectin which binds with an association constant of 1.0 X 10(6) M-1. The carbohydrate specificity of the S. sclarea lectin has been determined in detail, using well defined monosaccharide, oligosaccharide, and glycopeptide structures. The lectin was found to be specific for terminal N-acetylgalactosamine (GalNAc) residues. It binds preferentially alpha GalNAc determinants either linked to Ser or Thr (as in Tn structures) or linked in 1-3 to a beta GalNAc or to an unsubstituted beta Gal. Although more weakly, the lectin binds beta GalNAc residues linked in 1-4 to a beta Gal (as in Cad structures). It does not recognize beta GalNAc determinants linked in 1-3 to a Gal (as in globoside) or the alpha GalNAc residues of blood group A structures.
Asunto(s)
Acetilgalactosamina/metabolismo , Galactosamina/análogos & derivados , Lectinas/aislamiento & purificación , Semillas/análisis , Aminoácidos/análisis , Calcio/metabolismo , Metabolismo de los Hidratos de Carbono , Secuencia de Carbohidratos , Hemaglutinación , Punto Isoeléctrico , Cinética , Magnesio/metabolismo , Manganeso/metabolismo , Peso Molecular , Lectinas de PlantasRESUMEN
The O-glycosylation of leukosialin, a major sialoglycoprotein found on leukocytes, has been studied in the human erythroleukemic cell line K562. The appearance of its O-linked chains has been followed in pulse-chase experiments with [35S]methionine by immunoprecipitation with an anti-peptide antiserum as well as with a lectin from Salvia sclarea seeds (SSA) specific for GalNAc-Ser/Thr and the peanut (Arachis hypogaea) agglutinin (PNA) which recognizes Gal beta 1----3GalNAc-Ser/Thr structures. An O-glycan-free precursor was converted into the fully O-glycosylated mature form within the 10-min labeling period and no intermediates carrying only GalNAc-Ser/Thr structures could be detected. The ionophore monensin was used in order to slow down intracellular traffic and thus O-glycan synthesis. The drug partly inhibited the transport from rough endoplasmic reticulum (RER) to the Golgi and also the cell-surface expression of leukosialin. It was found to have a marked effect on the synthesis of O-linked carbohydrate structures of leukosialin since the amount of O-glycans containing only GalNAc or NeuNAc alpha 2----6GalNAc was significantly increased after monensin treatment. Under these conditions the biosynthesis of the N-glycan on leukosialin was completely arrested in an endoglycosidase-H-sensitive step of processing, whereas the O-glycans already contained galactose and sialic acid although at a reduced level. On the other hand, the small amounts of leukosialin expressed on the cell surface of monensin-treated cells carried the same glycans as those remaining blocked inside the cell. In addition, immunocytochemical studies using SSA and PNA on untreated K562 cells suggested the absence of detectable amounts of GalNAc-Ser/Thr-bearing glycoproteins in the RER as well as in the Golgi. In contrast Gal beta 1----3GalNAc structures could be detected on intracellular membranes which were tentatively identified as the cis-Golgi. Together these results lead us to the following conclusions: N-glycan transfer occurs in the RER before the initiation of O-glycans which takes place at the entrance of the protein into the Golgi; further elongation of O-glycans with galactose and sialic acid follows very rapidly, probably before the final processing of N-glycans to complex-type structures.
Asunto(s)
Antígenos CD , Aparato de Golgi/metabolismo , Leucemia Eritroblástica Aguda/metabolismo , Sialoglicoproteínas/metabolismo , Transporte Biológico/efectos de los fármacos , Línea Celular , Cromatografía en Gel , Electroforesis en Gel de Poliacrilamida , Retículo Endoplásmico/metabolismo , Glicósido Hidrolasas , Glicosilación , Humanos , Lectinas , Leucemia Eritroblástica Aguda/patología , Leucosialina , Microscopía Electrónica , Monensina/farmacología , Oligosacáridos/aislamiento & purificación , Polisacáridos/biosíntesis , Polisacáridos/aislamiento & purificaciónRESUMEN
Leukocytes express a major sialoglycoprotein, leukosialin, of which the apparent molecular weight (mol wt) can be variable according to the differences in O-glycans attached to this molecule. In the present study, we analyzed the structures of O-glycans attached to leukosialin present in various T-lymphocytic leukemia cells. T-lymphoid cells from patients with acute T-lymphocytic leukemia express a large amount of the branched hexasaccharides, NeuNAc alpha 2----3Gal beta 1----3(NeuNAc alpha 2----3Gal beta 1----4GlcNAc beta 1----6)GalNAc, which are also expressed in activated normal T lymphocytes, but that are almost absent in resting normal T lymphocytes. T-lymphoid cells from patients with chronic T-lymphocytic leukemia, on the other hand, mainly express the tetrasaccharides NeuNAc alpha 2----3Gal beta 1----3(NeuNAc alpha 2----6)GalNAc on leukosialin, but they also express a small significant amount of the hexasaccharides. The same hexasaccharides can be detected in thymocytes. The increased amount of the hexasaccharides in acute leukemia is associated with increased activity of beta 1----6 GlcNAc-transferase, a key enzyme in forming the hexasaccharides. Immunoblot analysis of cell lysates showed that monoclonal antibody (MoAb) T-305 reacts preferentially with leukosialin of high mol wt containing the hexasaccharides. These findings indicate that T-lymphocytic leukemia cells reexpress the oligosaccharides present in immature cells.
Asunto(s)
Antígenos CD , Leucemia de Células T/metabolismo , Oligosacáridos/biosíntesis , Sialoglicoproteínas/biosíntesis , Anticuerpos Monoclonales , Conformación de Carbohidratos , Secuencia de Carbohidratos , Línea Celular , Membrana Celular/metabolismo , Cromatografía en Gel , Humanos , Leucosialina , Datos de Secuencia Molecular , Peso Molecular , Oligosacáridos/aislamiento & purificación , Sialoglicoproteínas/análisis , Sialoglicoproteínas/aislamiento & purificación , Transferasas/metabolismoRESUMEN
By use of threading methods, the C-terminal region of uridine diphospho-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases (ppGalNAc-transferases) was predicted to have the same fold as the lectin-domain of the plant cytotoxins ricin and abrin-a, for which crystal structure are available. The sequence identities are very low. Nevertheless, the amino acids involved in the hydrophobic core essential for the structure stability and the cysteine residues are conserved. In addition, the amino-acids involved in carbohydrate binding are conserved in ppGalNAc-transferases. The extra C-terminal domain of these enzymes is therefore a putative glycan-binding domain. A model of the lectin-like domain of human ppGalNAc-transferase T1 was built using knowledge based methods. Geometry optimization of the complex with galactose allowed prediction that this domain could bind this monosaccharide. However, the interaction seems to be rather weak, and at the moment there is no evidence that ppGalNAc-transferases displays a lectin activity in vivo.
Asunto(s)
Lectinas/química , Modelos Moleculares , N-Acetilgalactosaminiltransferasas/química , Pliegue de Proteína , Abrina/química , Secuencia de Aminoácidos , Sitios de Unión , Simulación por Computador , Glicosilación , Humanos , Datos de Secuencia Molecular , Ricina/química , Alineación de Secuencia , Polipéptido N-AcetilgalactosaminiltransferasaRESUMEN
Aqueous extracts of human neoplastic and adjacent normal colonic mucosa were investigated for hemagglutination inhibition of both the anti-A serum and the Dolichos biflorus lectin. The anti-A antiserum was inhibited by the extracts from neoplastic tissues to a much higher extent than by that from normal mucosa; the inhibition was strictly dependent on the blood group and the secretor status of the individual. The inhibition titers against the Dolichos lectin were much lower for the tumor than for the normal tissue and the inhibition of this lectin was not dependent on blood group and secretor status. In addition, studies on the specificity of both agglutinins showed that only the anti-A antiserum reacted with the blood group A antigen in the colonic mucus whereas the Dolichos lectin reacted with a different substance which was not related to the blood group ABO system. The Dolichos reactive mucin was isolated by gel chromatography and by affinity chromatography on Dolichos-Sepharose. The partially purified mucin did not show any blood group A or H activity but reacted with all GalNAc specific lectins tested. A very high specific activity was obtained against the Dolichos biflorus lectin whereas the agglutinins from Salvia sclarea, Glycine max. (soybean) and Helix pomatia were less strongly inhibited no matter whether blood group A1, Tn, or Cad erythrocytes were used. By far the highest inhibitory activity was found against the human anti-Sd(a) antiserum regardless of whether the red blood cells were Cad or Sd(a+). By gel chromatography an equally pure mucin fraction could be obtained from neoplastic tissues which did not bind to either the anti-A antiserum nor the GalNAc specific lectins but could inhibit the anti-Sda antiserum at a far lower specific activity than the normal preparation.